SGO 2023 Conference Coverage on VuMedi
SGO 2023 GOG 3026 Phase II Trial of Letrozole + Ribociclib in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary, Fallopian Tube, or Peritoneum
By
SGO 2023 Conference Coverage on VuMedi
FEATURING
Brian Slomovitz
By
SGO 2023 Conference Coverage on VuMedi
FEATURING
Brian Slomovitz
Comments 0
Login to view comments.
Click here to Login
